DEK gene knockout, silencing, and targeted inhibitors down-regulated PINK1-Parkin-mediated mitophagy, NLRP3 inflammasome activation, and apoptosis, thereby improving airway inflammation in asthma. This evidence concerns the gene DEK and asthma.